[ SHOWREEL ] 2025 / 2026
0000 RPM

Biotech Pharma Med‑device
visuals,
pressurized.

[ A-01 / Manifesto ]

A creative studio that refuses to let science companies look like science companies. We build web, film, and identity for the teams reshaping human biology.

Watch showreel
Index
14
biotech launches
$840M
client raises
09
series-A sites
Scroll
[ B-01 / Orbit ]
Trusted by founders at the frontier — gene therapy, CRISPR, cell engineering, single-cell genomics, precision oncology, and beyond.
helix/12
PARSE.NOVA
M—BIO
Stratum
◎ ORCA
NUCLEOID
fathom·rx
△ AXIOM
[ C-01 / Capabilities ]

Three disciplines.
One centripetal force.

01 / 03 WEB
console.helix12.bio  ·  oncology / hx-12a
HELIX/12·console
SECURE · GxP ⌘K
HX-12A / KRAS G12C / NSCLC · 2L

Map the
tumor._
Make the drug.

Single-cell resolution. Closed-loop trial design. A precision oncology platform that reads the patient before it writes the prescription.

RESPONSE · COHORT-A
42%
+11.4 vs SoC
MEDIAN PFS
9.6mo
+2.3 mo
ENROLLED
184/220
28 sites · 6 ctry
NEXT MILESTONE
DSMB·24d
Apr 28 · interim
[01] NCT-06842910 · Phase II · Open enrolment
v3.14.2 · build 2184 · Read the dossier →

Investor-ready
web craft.

Marketing sites, clinical portals, and IR pages engineered for the moment a boardroom opens the tab. Sub-second loads, accessibility beyond compliance, and typography that makes a Series-B feel inevitable.

  • Brand + product sites
  • Clinical trial portals
  • Investor relations
  • Headless CMS & DAM
  • Performance & SEO
Scope web engagement
02 / 03 VIDEO
REC ●
01:24:03:12
CASE / PARSE.NOVA — SC3 LAUNCH FILM
Every cell, a sentence.

Cinema-grade
science storytelling.

Launch films, MOA animations, and investor reels that translate a 40-page deck into 90 seconds of "we need to be in this round." Directed with the craft of a commercial house and the rigor of a regulatory reviewer.

  • Launch films & sizzles
  • Mechanism-of-action animation
  • Investor & KOL reels
  • 3D molecular & cellular
  • Conference booth content
Scope film engagement
03 / 03 GRAPHIC
EDITION 001
Molecular
Cartography
STRATUM BIO 2025 — ANNUAL
FIG. 03 — TARGET BINDING
Series B Deck
NUCLEOID

Identity, print,
pitch, and paper.

Brand systems, investor decks, scientific publications, and conference collateral. The surface area where credibility is either built or quietly lost — we make sure yours is the former.

  • Brand identity systems
  • Investor & pitch decks
  • Scientific publications
  • Annual & impact reports
  • Conference & trade show
Scope design engagement
[ D-01 / Selected ]

Recent orbits.

Open the vault
FEATURED / 001
Parse.Nova
Single-cell analytics · Brand + launch site
2025 — WEB / BRAND
002
Helix/12
Oncology · Launch film
FILM
003
Stratum Bio
CRISPR gene editing · Annual
PRINT
Nucleoid
004
Nucleoid
Cell therapy · Series B deck
BRAND
[ E-01 / Method ]

Four rotations
per engagement.

01 · DISCOVERY
Load

Science-first intake. We read the papers. We sit in the boardroom. We ride the lab tour.

02 · STRATEGY
Accelerate

Positioning and narrative mapped to stage — pre-IND through IPO. Audience-aware messaging.

03 · CRAFT
Spin

Design and production. Creative direction from a studio that refuses stock-photo biotech.

04 · LAUNCH
Release

Ship. Measure. Iterate. The centrifuge doesn't stop spinning after the launch.

[ F-01 / From the field ]
“They made us look like the platform company we knew we were — two quarters before our data said we were. The site closed our Series B.”
DR. MAYA TANAKA
Co-founder & CEO, Parse.Nova